Table 4 Riaz Pet Peeves

• SPIRIT items left blank or marked N/A without rationale

• Page numbers missing from protocol but referenced in the SPIRIT Checklist

• Failure to provide any details about the groups involved in trial oversight and management

• Incomplete description of randomization and allocation processes

• Not including enough detail or justification in the sample size calculation to allow replication

• Not enough detail on how potential harms will be assessed

• Failure to specify how authorship will be determined in future trial publications (including any use of professional writers)

• Failure to include a model consent form or (alternatively) details about its contents

• Failure to consider the collection of blood and biomarker levels as “biological specimens”